Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | -0.37% | -2.90% | -7.27% |
02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.27% | 25.28M | |
+37.84% | 723B | |
+34.28% | 595B | |
-4.63% | 369B | |
+20.02% | 332B | |
+2.60% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.26% | 168B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Transcript : Acasti Pharma Inc. - Special Call